GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 595A2B
Technology

Bio-IT World Conference & Expo 2026

T

he Bio-IT World Conference & Expo is the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Now in its 25th year, the event convenes more than 2,900 leaders from biopharma, clinical research, healthcare, informatics, and technology to exchange ideas, showc…

Visit the official site
14Voices
6Underwriters
0Exhibitors
0On the bill · sessions
20Companies · in total
§I

The Voices

Programmed at Bio-IT, in alphabetical order.
Arman Zaribafiyan, PhD
Head of Strategic Alliances, AI Simulation, SandboxAQ · SandboxAQ
Catherine Brownstein, PhD
Manager, Molecular Genomics Core Facility, Boston Children's Hospital; Scientific Director, Manton Center for Orphan Disease Research Gene Discovery Core; Assistant Professor, Harvard Medical School · Boston Children's Hospital / Harvard Medical School
Christina Taylor, PhD
Senior Science Fellow and Computational Molecular Design Lead, Bayer · Bayer
Dylan Livingston
Founder and President, The Alliance for Longevity Initiatives (A4LI) · The Alliance for Longevity Initiatives (A4LI)
Jeremy L. Jenkins, PhD
US Head, Discovery Sciences, Novartis BioMedical Research · Novartis BioMedical Research
Jonathan B. Gilbert, PhD
Senior Director, Ecosystem Growth and Contributor Partnerships, Eli Lilly and Company · Eli Lilly and Company
José-Tomás Prieto, PhD
Director of AI Programs, Apheris · Apheris
Mohammed AlQuraishi, PhD
Assistant Professor, Systems Biology, Columbia University · Columbia University
Morgan Cheatham, MD
Partner, Head of Healthcare & Life Sciences, Breyer Capital · Breyer Capital
Sebastien Lefebvre
Head of Technology, Data and AI, Aurelis Insights · Aurelis Insights
Susan J. Ward, PhD
Founder & Executive Director, cTAP · cTAP
Thomas Bartlett
Ambassador, MG Uniter Myasthenia Gravis, Amgen · Amgen
William Van Etten, PhD
Co-Founder & Principal Consultant, StarfleetBio · StarfleetBio
Woody Sherman, PhD
Founder and Chief Innovation Officer, Psivant Therapeutics · Psivant Therapeutics
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
BenchlingPlatinum
BioTeamPlatinum
DotmaticsPlatinum
RevvityPlatinum
SeqeraPlatinum
ZS AssociatesPlatinum
Intermission
Part the Second · For the Buyer

An audience of 20 companies, parsed from the program.

“Twenty companies in attendance.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
0All threespeak · spons · exh
6Sponsoringsponsor only
0Exhibitingexhibitor only
14Speakingspeaker only
№ 02Fig. 02 — The Voices, by Seniority

71% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite17%
  • Founder / Owner429%
  • Director / Head of536%
  • Manager / Lead17%
  • Other roles321%

Of 14 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01BenchlingSp·P
  2. 02BioTeamSp·P
  3. 03DotmaticsSp·P
  4. 04RevvitySp·P
  5. 05SeqeraSp·P
  6. 06ZS AssociatesSp·P
  7. 07Amgen1V
  8. 08Apheris1V
  9. 09Aurelis Insights1V
  10. 10Bayer1V
  11. 11Boston Children's Hospital / Harvard Medical School1V
  12. 12Breyer Capital1V
  13. 13Columbia University1V
  14. 14cTAP1V
№ 04Fig. 04 — By Tier
platinum6
100% of 6